This medication is relevant for use in areas where symptomatic management is appropriate, assisting patients with managing fever and pain. It is commonly used to help with symptoms related to acute physical discomfort and systemic imbalance.

The preparation is applied across domains where symptomatic support is needed, typically addressing symptoms of acute mild-to-moderate pain—such as headache, toothache, muscular aches, and menstrual pain—and the elevated body temperature and systemic malaise characteristic of colds and flu-like infections.

“The symptomatic relief offered helps patients cope more steadily with difficult episodes by easing distress.”

The core benefit is two-fold: it provides symptomatic relief that helps ease the overall pain and fever burden, and the included Vitamin C component may assist with supportive benefit during periods of acute physical strain. This assists with maintaining functional stability when symptoms interfere with routine activities.

---

Quick Fact: Relief for Acute Discomfort
Symptom Focus	Pain, Fever, Systemic Aches
Typical Context	Seasonal Illness, Episodic Pain
Primary Benefit	Easing overall symptom load

Regulatory References

1. Health Canada's Acetylsalicylic Acid Labelling Standard

Who Can and Cannot Use Аспирин-C? (Official Regulatory Information)

Official regulatory documents strictly define the patient groups eligible for Аспирин-C based on the Acetylsalicylic Acid (ASA) component. Use is permitted for adults under standard labeled conditions, though older adults (aged ge 60 years) must proceed with caution.

Absolute Contraindications

The medicine must not be used by individuals with acute gastrointestinal ulcers, a history of ASA-induced asthma, severe liver or kidney failure, haemorrhagic diathesis (bleeding disorders), or severe, uncontrolled heart failure. Use is also contraindicated in the third trimester of pregnancy and in patients receiving 15 mg or more of methotrexate weekly.

Age and Conditional Restrictions

Use is not recommended for children and adolescents with feverish illnesses, unless prescribed by a physician, due to the established risk of Reye's syndrome. For pregnancy, use is prohibited in the third trimester and restricted in the first and second trimesters. Patients with impaired (non-severe) hepatic or renal function must use the medicine with caution, and it must be discontinued before any scheduled surgery.

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Аспирин-C (Acetylsalicylic Acid/Ascorbic Acid) as stated in government regulatory labeling.

---

Formal Interaction Restrictions

Classification	Interacting Entity	Regulatory Constraint	Outcome Basis
Contraindicated	Methotrexate (ge 15 mg/week)	Must not be co-administered.	Reduced renal clearance, increased toxicity.
Contraindicated	Other non-selective NSAIDs	Must not be co-administered.	Additive risk of gastrointestinal bleeding.

---

Official Documentation of Pharmacological Interaction

The Acetylsalicylic Acid (ASA) component is documented to interact with several classes of medicines by either increasing the risk of bleeding or altering drug exposure.

Co-administration with Anticoagulants (e.g., Warfarin, Heparin) and SSRIs carries a documented enhanced risk of hemorrhage due to additive effects on hemostasis and gastrointestinal integrity. ASA also increases the plasma concentration of Valproate by displacing it from protein binding sites and inhibits its metabolism, an exposure-altering effect.

ASA reduces the therapeutic effectiveness of uricosurics (e.g., Probenecid) by interfering with renal transport mechanisms, and may decrease the effect of some diuretics. Specific constraints exist for the Ascorbic Acid component; it should be introduced only after commencing treatment with Deferoxamine for severe chronic iron overload. Finally, consumption of three or more alcoholic drinks daily is officially associated with an increased risk of gastrointestinal bleeding when taking ASA.

How Аспирин-C Works: Pharmacodynamic Mechanism

The core mechanism relies on acetylsalicylic acid acting as an irreversible inhibitor of the cyclooxygenase (COX) enzymes through acetylation of a serine residue ( Ser)-530 within the enzyme's active site.

This blockade prevents the conversion of arachidonic acid into pro-inflammatory mediators, primarily prostaglandins ( PGE2). Suppression of PGE2 synthesis in the peripheral tissues results in a reduction of localized inflammatory signaling and nociceptor sensitivity.

Simultaneously, the central inhibition of PGE2 in the hypothalamus modulates the central thermoregulatory set point, leading to a physiological response of heat dissipation. In platelets, the irreversible suppression of COX-1 persists for the cell's lifespan, leading to a profound, long-term inhibition of Thromboxane A2 ( TXA2) production and subsequent inhibition of platelet aggregation. Ascorbic acid supports general cellular redox states without directly modifying the COX inhibition mechanism.

Administration Guidelines for Аспирин-C (Aspirin + Vitamin C)

This guide outlines the instructions for the proper use of the effervescent tablet formulation of Аспирин-C.

Dosing and Frequency

The standard single dose for adults and adolescents 15/16 years is 1 to 2 effervescent tablets.

Feature	Guideline
Dose Interval	Repeat the single dose every 4 to 8 hours, as required.
Maximum Daily Dose (MDD)	Do not exceed a total of 6 tablets within any 24-hour period.

Preparation and Intake Requirements

Аспирин-C is an effervescent product intended for oral administration after preparation.

1. Preparation: The tablet must be dissolved completely in a full glass of water.
2. Timing: The solution should be drunk immediately upon dissolution.
3. Food Constraint: It is critical that the medicine not be taken on an empty stomach. Consume the dose preferably with or after a meal to minimize potential gastric irritation.

Use Context and Duration

Use of Аспирин-C is restricted to adults and adolescents over 15 or 16 years of age. Due to the formulation's composition, the self-medication course must not be taken for more than 4 consecutive days without medical consultation.

Research Evidence / Overview of Studies for Аспирин-C

---

Evidence for Symptomatic Relief of Cold and Flu-like Conditions

Research involving Аспирин-C (Acetylsalicylic Acid and Ascorbic Acid) for individuals with acute upper respiratory tract infections has been primarily conducted using short-term, randomized controlled trials (RCTs). These trials were relevant in trials assessing short-term or episodic symptom patterns and often included adults experiencing mild-to-moderate fever and pain. The research examined outcomes related to physical discomfort and systemic or functional imbalance, such as scores for overall symptom severity and measures of antipyresis (fever reduction).

Studies focusing on episodes where symptoms become more noticeable reported that in the observed populations, there were patterns observed in the studies related to changes measured during the study period in scores for physical discomfort and fever. However, evidence derived from settings with varying symptom burdens also indicates that results may be mixed or inconsistent regarding outcomes related to respiratory symptoms that are not defined by pain, such as congestion or cough.

---

Evidence for Relief of General Acute Pain

The research base relevant to general acute pain, such as headache or muscular aches, mainly relies on systematic reviews that aggregate data from numerous single-dose Randomized Controlled Trials (RCTs). These trials assessed the effect of the primary analgesic ingredient, Acetylsalicylic Acid (ASA), in adults who experienced established pain. The outcomes studied were used in research exploring short-term symptom changes, such as the percentage of participants who achieved a defined level of pain relief.

Data show patterns related to outcomes capturing phases of heightened symptom activity. The findings describe group patterns, indicating that a significant portion of participants in the reviewed trials met the criteria for pain relief within the first few hours after administration. However, the majority of this high-level research focuses on the ASA component alone, and comparative evidence with the combination formula is often lacking.

---

Research on the Supportive Role of the Ascorbic Acid Component

Research has also explored the addition of Ascorbic Acid (Vitamin C). Studies utilized RCTs and other research designs to examine its role in the combination. This research examined outcomes monitoring physiological strain or stress and Ascorbic Acid's effect on the body's nutrient status. Studies monitored changes measured during the study period, reporting an association with increases in plasma Vitamin C concentration measurements and shifts in biomarkers of oxidative stress.

What remains uncertain is the direct clinical translation of the observed biomarker shifts to patient-reported symptomatic relief or long-term clinical well-being. The data are often derived from studies that included populations with specific underlying chronic conditions, meaning results apply only to the populations studied.

---

What is Still Uncertain About the Research for Аспирин-C

Studies contribute to the broader evidence landscape, but several areas of uncertainty remain. Data are still emerging regarding the specific contribution of the Ascorbic Acid component to the primary pain and fever relief outcomes. Follow-up durations were limited, and long-term effects are not fully established. Subgroup findings are uncertain, as the populations studied were often narrow, meaning that data for certain groups (like children or those with complex health profiles) remain insufficient.

Key Studies & References

1. Aspirin: MedlinePlus Drug Information
2. Ascorbic Acid (Vitamin C): MedlinePlus Drug Information
3. Guidance Document - Acetylsalicylic Acid Labelling Standard - Canada.ca (Health Canada)

Common questions about Аспирин-C (FAQ)

---

Q: What is the main difference between Аспирин-C and regular aspirin?

Official product information notes that Аспирин-C is a fixed-dose combination of two active ingredients: Acetylsalicylic Acid (ASA) and Ascorbic Acid (Vitamin C). Regular aspirin typically contains only ASA. Additionally, Аспирин-C is commonly supplied as an effervescent tablet designed to be dissolved in water, while regular aspirin is often a solid tablet.

---

Q: Why is vitamin C included in the formula?

The Ascorbic Acid (Vitamin C) component is officially described as fulfilling a supportive role in the formulation. It is intended to fulfill a supportive role, which may include antioxidant support, as described in the official product information.

---

Q: How quickly does Аспирин-C typically start to work?

Studies on the Acetylsalicylic Acid (ASA) component indicate that pain relief generally begins within the first 30 minutes after administration. The effervescent form is typically associated with a faster dissolution, which may contribute to the observed absorption characteristics of the active ingredient.

---

Q: How long do the effects of Аспирин-C last?

The duration of effect is generally reflected in the official dosing guidelines for repeat administration. These guidelines suggest that the therapeutic effect lasts several hours.

---

Q: Does the effervescent form contain sodium?

Yes, the effervescent tablet formulation contains sodium. Official product labeling lists excipients (inactive ingredients) such as sodium bicarbonate, sodium carbonate, and/or monosodium citrate, which are necessary to create the soluble, fizzy form.

---

Q: Is it described in official sources that Аспирин-C can cause ringing in the ears?

Yes, Tinnitus (ringing in the ears) is a documented adverse reaction listed in official product information. Regulatory documents specify that this is often a Dose-Related effect, meaning it can be associated with higher levels of exposure.

---

Q: Is the risk of side effects higher when Аспирин-C is taken on an empty stomach?

Regulatory labeling advises that this medicine should not be taken on an empty stomach and is preferably consumed with or after a meal. This requirement is established in official labeling to address the potential for gastric irritation.

---

Q: What are the signs of taking too much Аспирин-C according to official information?

Official documents describe a state of toxicity known as Salicylism associated with high doses or prolonged use of the drug. The signs of this state include severe tinnitus (ringing in the ears), impaired hearing, and vertigo (dizziness).

---

Q: Does Аспирин-C contain only aspirin, or are there other ingredients?

No, the medicine contains two active ingredients: Acetylsalicylic Acid and Ascorbic Acid. In addition to these, the official product labeling specifies that the effervescent tablet contains several excipients (inactive ingredients) such as various sodium salts and citric acid, which aid in the preparation and dissolution.

---

Q: Can people with high blood pressure use Аспирин-C?

Regulatory documents indicate that use by individuals with high blood pressure (hypertension) or heart disease requires consideration by a healthcare professional. The medicine is formally restricted only in cases of severe, uncontrolled heart failure.

---

Q: Does using Аспирин-C affect the kidneys or liver?

Official product information lists impaired liver or kidney function as a possible adverse reaction. Furthermore, the medicine is formally contraindicated (restricted from use) in patients who have severe liver failure or severe kidney failure.

---

Q: Can Аспирин-C be taken for muscle soreness after exercise?

The official approved uses for the medicine include the symptomatic relief of general acute pain. This indication can encompass temporary relief for common aches and muscular discomfort.

---

Q: Does Аспирин-C interact with common over-the-counter pain relievers?

Yes, official regulatory labeling states that this medicine is formally contraindicated (must not be taken) alongside other non-selective NSAIDs (Nonsteroidal Anti-inflammatory Drugs). This restriction is in place due to an increased and additive risk of gastrointestinal bleeding.

---

Q: What kind of foods or drinks should be avoided when using Аспирин-C?

Official regulatory information advises caution regarding alcohol consumption. Taking the Acetylsalicylic Acid component alongside alcohol is associated with an increased risk of gastrointestinal bleeding.

---

Q: Can teenagers or children use Аспирин-C?

Official use is generally restricted to adults and older adolescents. The exact minimum age requirement is defined in the product's official labeling. Furthermore, the medicine is not recommended for children and adolescents experiencing feverish illnesses due to the documented risk of Reye's syndrome.

---

Q: What happens if a dose of Аспирин-C is missed?

Official patient instructions address missed doses by focusing on preventing excessive intake. The guidance generally indicates that a skipped dose should not be doubled, and the next dose should be taken at the regularly scheduled time.

---

Q: Does Аспирин-C contain caffeine or other stimulants?

Official ingredient lists for this fixed-dose combination (Acetylsalicylic Acid and Ascorbic Acid) list only these two active substances and excipients. Caffeine or other stimulants are not listed as ingredients in the core product information.

---

Q: Why are people often told to dissolve the tablet completely before use?

The requirement to dissolve the effervescent tablet completely is a necessary step in the administration process. This preparation is intended to ensure the active ingredients are fully dissolved. This aids in the effective delivery and absorption of the Acetylsalicylic Acid component, as specified in the administration instructions.

---

Q: Are there different strengths of Аспирин-C available?

Product labeling specifies the active ingredient strengths per tablet, typically 400 mg Acetylsalicylic Acid and 240 mg Ascorbic Acid. While this is the standard strength, different strengths of the specific combination product may be available across various global markets.

---

Q: Can this drug be purchased without a prescription in most places?

In most major markets, Аспирин-C is typically classified as an Over-the-Counter (OTC) or Pharmacy-Only medicine. This means it is generally available for purchase without the need for a formal prescription from a doctor.

---

Q: What is the official advice regarding driving or operating machinery after using Аспирин-C?

Official safety advice suggests that activities such as driving or operating machinery should be considered carefully if documented side effects, such as dizziness or vertigo, are experienced.

---

Q: Are there any descriptions of Аспирин-C being used for menstrual pain?

Yes, official regulatory labeling and product information for the Acetylsalicylic Acid component includes the symptomatic relief of menstrual pain (dysmenorrhea) as one of the approved therapeutic indications.

---

Q: Is it described that Аспирин-C can cause dizziness or drowsiness?

Official documentation lists vertigo (dizziness) as a potential side effect associated with the medicine. However, drowsiness is generally not listed as a common or specific adverse effect in the core product information.

---

Q: Is Аспирин-C helpful for joint pain or arthritis?

The medicine is indicated for the symptomatic relief of general acute pain and fever. Some regulatory labels for the Acetylsalicylic Acid component include the temporary relief of minor pain of arthritis among its approved uses.

How to Store and Dispose of Аспирин-С

The official storage conditions for Аспирин-С (Acetylsalicylic Acid and Ascorbic Acid effervescent tablets) strictly focus on maintaining product stability and ensuring safe access.

---

Required Storage Conditions

Condition	Requirement
Temperature	Store at controlled room temperature, typically below 25°C (77°F).
Protection	Must be stored to protect from moisture, light, and freezing.
Packaging	Keep the medicine in its original container and do not use after the expiry date or if the packaging is damaged.
Child Safety	Keep this medicine out of the sight and reach of children.

Official Disposal Instructions

Unused or expired medicinal products must not be discarded in wastewater or household trash. Regulatory guidance requires asking a pharmacist how to dispose of the product or using an authorized drug take-back program. Disposal must align with applicable local regulations.